SCHEMBL667984

SCHEMBL667984

[c]1c(-c2ccccc2-c2ccccc2)ccc2ccccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.34
HSD17B10 Q99714 2/20 0.34
HPGD P15428 2/20 0.34
BCL2L1 Q07817 1/20 0.34
CYP2A6 P11509 1/20 0.34
MAPK1 P28482 1/20 0.34
GPR55 Q9Y2T6 1/20 0.34
DCUN1D1 Q96GG9 2/20 0.33
TNF P01375 1/20 0.33
PTGS2 P35354 1/20 0.32
DCUN1D2 Q6PH85 1/20 0.32
MAPT P10636 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 1/20 0.32
MPI P34949 1/20 0.32
KMT2A Q03164 1/20 0.32
DPP4 P27487 1/20 0.31
BACE1 P56817 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC2 Q92769 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL79020 0.84 ALDH1A1 (0.35) ALDH1A1HSD17B10CYP2A6MEN1KMT2A
SCHEMBL3149589 0.80 ALDH1A1 (0.38) ALDH1A1HSD17B10BCL2L1MAPK1BACE1
SCHEMBL239122 0.79 CYP2A6 (0.37) ALDH1A1HSD17B10HPGDCYP2A6TSHR
SCHEMBL668632 0.78 ALDH1A1 (0.38) ALDH1A1HSD17B10HPGDCYP2A6MAPK1
SCHEMBL669473 0.78 DNMT1 (0.38) ALDH1A1HSD17B10HPGDCYP2A6MAPK1
SCHEMBL3249728 0.77 ALDH1A1 (0.34) ALDH1A1HSD17B10HPGDCYP2A6DCUN1D1
SCHEMBL4609078 0.77 MAPK1 (0.39) ALDH1A1HSD17B10HPGDCYP2A6MAPK1
SCHEMBL3240933 0.77 CYP2A6 (0.39) ALDH1A1HPGDCYP2A6GPR55DCUN1D1
SCHEMBL27802208 0.77 C1R (0.30)
SCHEMBL10501303 0.77 ALDH1A1 (0.39) ALDH1A1HSD17B10HPGDBCL2L1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7132536-B2 Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-11-07 US claimed
US-6555580-B2 Treating arteriosclerosis and hypercholesterolaemia BAYER AKTIENGESELLSCHAFT (DE) 2003-04-29 US claimed
EP-0409077-B1 1-Aza-butadienes and fungicides containing them BASF AG (DE) 1993-10-20 EP claimed
EP-2502908-B1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO (JP) 2018-01-03 EP disclosed
EP-1990844-B1 ORGANIC ELECTROLUMINESCENT DEVICE IDEMITSU KOSAN CO (JP) 2016-07-20 EP disclosed
US-9278926-B2 Aromatic amine derivative, and organic electroluminescent element comprising same IDEMITSU KOSAN CO., LTD. (JP) 2016-03-08 US disclosed
US-9214636-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-12-15 US disclosed
EP-2085371-B1 FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE USING THE FLUORANTHENE COMPOUND, AND ORGANIC ELECTROLUMINESCENT MATERIAL-CONTAINING SOLUTION IDEMITSU KOSAN CO (JP) 2015-10-07 EP disclosed
US-9120748-B2 Fluoranthene compound, organic electroluminescence device using the same, and solution containing organic electroluminescence material IDEMITSU KOSAN CO., LTD. (JP) 2015-09-01 US disclosed
US-8932735-B2 Aromatic amine derivative and organic electroluminescent element comprising the same IDEMITSU KOSAN CO., LTD. (JP) 2015-01-13 US disclosed
EP-2351759-B1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO (JP) 2014-05-14 EP disclosed
US-20090015144-A1 FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND SOLUTION CONTAINING ORGANIC ELECTROLUMINESCENCE MATERIAL IDEMITSU KOSAN CO., LTD. (JP) 2009-01-15 US disclosed
EP-2008992-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2008-12-31 EP disclosed
EP-2003135-A2 PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMENE OXIDE COMPOUND Nissan Chemical Industries, Ltd. (JP) 2008-12-17 EP disclosed
EP-1990844-A1 ORGANIC ELECTROLUMINESCENT DEVICE Idemitsu Kosan Co., Ltd. (JP) 2008-11-12 EP disclosed
US-20080071099-A1 Method for Production of Optically Active Epoxy Compound, and Complex Used Therefor and Process for Producing the Same JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2008-03-20 US disclosed
US-20080004445-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-01-03 US disclosed
EP-1849778-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE EPOXY COMPOUND, COMPLEX FOR USE IN THE PROCESS, AND PROCESS FOR PRODUCING THE SAME Japan Science and Technology Agency (JP) 2007-10-31 EP disclosed
US-20070243411-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2007-10-18 US disclosed
EP-0017012-A2 Dyes and process for the generation of tints based on optionally substituted 2-amino-5-iminopyrrolenines BAYER AG (DE) 1980-10-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004445-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME TYR, MAOA, PRDM9 ALDH1A1 291/4885HSD17B10 3259/4885HPGD 3635/4885
US-20090015144-A1 FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND SOLUTION CONTAINING ORGANIC ELECTROLUMINESCENCE MATERIAL LEF1, ESD, AFF2 ALDH1A1 422/4885HSD17B10 2452/4885HPGD 2404/4885
US-20080071099-A1 Method for Production of Optically Active Epoxy Compound, and Complex Used Therefor and Process for Producing the Same EPRS1, PPOX, POR ALDH1A1 840/4885HSD17B10 1176/4885HPGD 209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.